OncoHealth

OncoHealth develops proprietary screening and diagnostic tests for cervical cancer and other cancers associated with human papillomavirus.

OncoHealth Corporation plans to commercialize novel, proprietary screening and diagnostic tests for cervical cancer and other cancers associated with the human papillomavirus. The company's technology platform includes proprietary biomarkers and robust detection technology that can enable the development of easy-to-use, high-throughput and cost-competitive assays.